Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析

◆英語タイトル:Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1669
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Alkermes Plc (ALKS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Alkermes Plc (Alkermes) is a biopharmaceutical company that focuses on the research, development and commercialization of drugs for the treatment of central nervous system (CNS) diseases. The company’s proprietary products include Aristada and Aristada Initio an extended-release intramuscular injectable suspension for the treatment of schizophrenia; and Vivitrol, a once-monthly, non-addictive, injectable medication for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence. It also grants license under its proprietary technologies to enable third parties to develop, commercialize and manufacture products. Alkermes sells its products primarily to wholesalers, specialty distributors and specialty pharmacies. The company also has a clinical pipeline of products that address CNS disorders such as multiple sclerosis, schizophrenia, depression and addiction. Alkermes is headquartered in Dublin, Ireland.

Alkermes Plc Key Recent Developments

Feb 13,2020 Alkermes reports financial results for the fourth quarter and year ended Dec. 31, 2019 and provides financial expectations for 2020
Nov 19,2019 Alkermes to acquire Rodin Therapeutics in $950m deal
Oct 23,2019 Alkermes reports third quarter 2019 financial results and implementation of restructuring
Oct 07,2019 Alkermes presents new health economics and outcomes research on patients with schizophrenia and bipolar I disorder at 2019 Psych Congress

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Alkermes Plc – Key Facts
Alkermes Plc – Key Employees
Alkermes Plc – Key Employee Biographies
Alkermes Plc – Major Products and Services
Alkermes Plc – History
Alkermes Plc – Company Statement
Alkermes Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Alkermes Plc – Business Description
Product Category: Aristada/Aristada Initio
Overview
Performance
Product Category: Vivitrol
Overview
Performance
Geographical Segment: Ireland
Performance
Geographical Segment: Rest of world
Performance
Geographical Segment: US
Performance
R&D Overview
Alkermes Plc – Corporate Strategy
Alkermes Plc – SWOT Analysis
SWOT Analysis – Overview
Alkermes Plc – Strengths
Alkermes Plc – Weaknesses
Alkermes Plc – Opportunities
Alkermes Plc – Threats
Alkermes Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Alkermes Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 13, 2020: Alkermes reports financial results for the fourth quarter and year ended Dec. 31, 2019 and provides financial expectations for 2020
Nov 19, 2019: Alkermes to acquire Rodin Therapeutics in $950m deal
Oct 23, 2019: Alkermes reports third quarter 2019 financial results and implementation of restructuring
Oct 07, 2019: Alkermes presents new health economics and outcomes research on patients with schizophrenia and bipolar I disorder at 2019 Psych Congress
Sep 13, 2019: Alkermes announces the appointment of Richard Gaynor, M.D. and Andy Wilson to its Board of Directors and the Retirement of Director Floyd Bloom, M.D.
Jul 25, 2019: Alkermes reports second quarter 2019 financial results
Apr 25, 2019: Alkermes reports first quarter 2019 financial results
Apr 24, 2019: Alkermes names C. Todd Nichols as Senior Vice President of Sales and Marketing
Apr 08, 2019: Alkermes announces departure of Jim Robinson
Apr 03, 2019: Alkermes expands awards program with focus on advancing research in schizophrenia
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Alkermes Plc, Key Facts
Alkermes Plc, Key Employees
Alkermes Plc, Key Employee Biographies
Alkermes Plc, Major Products and Services
Alkermes Plc, History
Alkermes Plc, Other Locations
Alkermes Plc, Subsidiaries
Alkermes Plc, Key Competitors
Alkermes Plc, Ratios based on current share price
Alkermes Plc, Annual Ratios
Alkermes Plc, Annual Ratios (Cont...1)
Alkermes Plc, Interim Ratios
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Alkermes Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Alkermes Plc, Performance Chart (2015 - 2019)
Alkermes Plc, Ratio Charts
Alkermes Plc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Alkermes Plc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adani Enterprises Ltd (ADANIENT):石油・ガス:M&Aディール及び事業提携情報
    Summary Adani Enterprises Ltd (Adani) is a diversified company with operations in resources, logistics and energy. It has interests in various businesses such as coal trading and mining, bunkering, renewable power generation, defense and aerospace, ports and special economic zones (SEZ), logistics, …
  • All in West! Capital Corporation:戦略・SWOT・企業財務分析
    All in West! Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary All in West! Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • NIIT Technologies Ltd (NIITTECH):企業の財務・戦略的SWOT分析
    Summary NIIT Technologies Ltd (NIIT Technologies) is a technology company that provides information technology solutions. The company provides software products such as AdvantageSuite, an insurance technology solution based on Microsoft Azure cloud platform. It offers services such as application ma …
  • Tulip Star Hotels Limited:企業の戦略・SWOT・財務分析
    Tulip Star Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary Tulip Star Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Veolia Environnement S.A.:企業の戦略・SWOT・財務分析
    Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report Summary Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Kotak Wealth Management:企業の戦略・SWOT・財務分析
    Kotak Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Kotak Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tactile Systems Technology Inc (TCMD):医療機器:M&Aディール及び事業提携情報
    Summary Tactile Systems Technology Inc (Tactile Medical) is a medical technology company that develops, manufactures and distributes medical devices for the treatment of chronic vascular diseases in a home setting. The company’s products are based on a unique, scalable platform. It offers products f …
  • LifeScan Inc:医療機器:M&Aディール及び事業提携情報
    Summary LifeScan Inc (LifeScan), a subsidiary of the Johnson & Johnson, develops, manufactures and markets blood glucose monitoring solutions for hospital and home use. The company’s product portfolio includes blood glucose meters; test strips and control solutions; lancing devices; diabetes managem …
  • Vivus Inc (VVUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Vivus Inc (Vivus) is a biopharmaceutical company which develops and commercializes next-generation therapeutics for addressing unmet needs in obesity, sleep apnea, diabetes and sexual health. The company's marketed products include, Qsymia (phentermine and topiramate extended-release), indic …
  • Edge Therapeutics Inc (EDGE)-製薬・医療分野:企業M&A・提携分析
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes a range of hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, …
  • ABPA Holdings Ltd:企業の戦略的SWOT分析
    ABPA Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Bureau Veritas SA:企業の戦略・SWOT・財務分析
    Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report Summary Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • UAC of Nigeria PLC:企業の戦略・SWOT・財務情報
    UAC of Nigeria PLC - Strategy, SWOT and Corporate Finance Report Summary UAC of Nigeria PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Trivitron Healthcare Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary Trivitron Healthcare Pvt Ltd (Trivitron) is a medical technology company that provides solutions to healthcare providers. The company’s products include radiography and c-arm systems, newborn screening, mammography, ultrasound, contrast media, breast biopsy system, bone densitometer, radiati …
  • Debiopharm Innovation Fund SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Debiopharm Innovation Fund SA (Debiopharm Innovation), formerly Debiopharm Diagnostics SA, a subsidiary of Debiopharm Group, is a patient care investment company that offers drug investments and development stage diagnostic solutions. The company offers investments for drugs on cancer severi …
  • Holmen AB:企業の戦略・SWOT・財務情報
    Holmen AB - Strategy, SWOT and Corporate Finance Report Summary Holmen AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • ITL Health Group (ITD):企業の財務・戦略的SWOT分析
    ITL Health Group (ITD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Eurofins Scientific SE:企業のM&A・事業提携・投資動向
    Eurofins Scientific SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurofins Scientific SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Clinova Ltd:企業の戦略的SWOT分析
    Clinova Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Sumitomo Realty & Development Co., Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆